Clemens B. Hug

Clemens B. Hug

Auto-generated profile, based on publicly available information

Clemens B. Hug

Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Cell
Verified
Journal Article
Closed access
CHClemens B. Hug
Clemens B. Hug
AGAlexis G. Grimaldi
Alexis G. Grimaldi
KKKai Kruse
Kai Kruse
JVJuan M. Vaquerizas
Juan M. Vaquerizas

15 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRSteve Rodriguez
Steve Rodriguez
CHClemens Hug
Clemens Hug
PTPetar Todorov
Petar Todorov
NMNienke Moret
Nienke Moret
SBSarah A. Boswell
Sarah A. Boswell
ASArtem Sokolov
Artem Sokolov
Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a large amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA) for another indication is a more rapid and less expensive option. We present DRIAD (Drug Repurposing In AD), a machine learning framework that quantifies potential associations between the pathology of AD severity (the Braak stage) and molecular mechanisms as encoded in lists of gene names. DRIAD is applied to lists of genes arising from perturbations in differentiated human neural cell cultures by 80 FDA-approved and clinically tested drugs, producing a ranked list of possible repurposing candidates. Top-scoring drugs are inspected for common trends among their targets. We propose that the DRIAD method can be used to nominate drugs that, after additional validation and identification of relevant pharmacodynamic biomarker(s), could be readily evaluated in a clinical trial.

1 December 2018 in Trends in Genetics
Verified
Journal Article
Open access
CHClemens B. Hug
Clemens B. Hug
JVJuan M. Vaquerizas
Juan M. Vaquerizas
The 3D structure of chromatin in the nucleus is important for the regulation of gene expression and the correct deployment of developmental programs. The differentiation of germ cells and early embryonic development (when the zygotic genome is activated and transcription is taking place for the first time) are accompanied by dramatic changes in gene expression and the epigenetic landscape. Recent studies used Hi-C to investigate the 3D chromatin organization during these developmental transitions, uncovering remarkable remodeling of the 3D genome. Here, we highlight the changes described so far and discuss some of the implications that these findings have for our understanding of the mechanisms and functionality of 3D chromatin architecture.

17 June 2016 in Bioinformatics
Verified
Journal Article
Open access
PDF file
KKKai Kruse
Kai Kruse
CHClemens B. Hug
Clemens B. Hug
Benjamín Hernández-RodríguezBenjamín Hernández-Rodríguez
Benjamín Hernández-Rodríguez
JVJuan M. Vaquerizas
Juan M. Vaquerizas
Summary: Eukaryotic genomes are hierarchically organized into topologically associating domains (TADs). The computational identification of these domains and their associated properties critically depends on the choice of suitable parameters of TAD-calling algorithms. To reduce the element of trial-and-error in parameter selection, we have developed TADtool: an interactive plot to find robust TAD-calling parameters with immediate visual feedback. TADtool allows the direct export of TADs called with a chosen set of parameters for two of the most common TAD calling algorithms: directionality and insulation index. It can be used as an intuitive, standalone application or as a Python package for maximum flexibility. Availability and implementation: TADtool is available as a Python package from GitHub (https://github.com/vaquerizaslab/tadtool) or can be installed directly via PyPI, the Python package index (tadtool). Contact:kai.kruse@mpi-muenster.mpg.de, jmv@mpi-muenster.mpg.de Supplementary information: Supplementary data are available at Bioinformatics online.

20 December 2024 in Cancer Discovery
Verified
Journal Article
Open access
TKTanjina Kader
Tanjina Kader
JLJia-Ren Lin
Jia-Ren Lin
CHClemens B. Hug
Clemens B. Hug
SCShannon Coy
Shannon Coy
YCYu-An Chen
Yu-An Chen
SSSandro Santagata
Sandro Santagata
High-grade serous ovarian cancer (HGSOC) originates from fallopian tube (FT) precursors. However, the molecular changes that occur as precancerous lesions progress to HGSOC are not well understood. To address this, we integrated high-plex imaging and spatial transcriptomics to analyze human tissue samples at different stages of HGSOC development, including p53 signatures, serous tubal intraepithelial carcinomas (STIC), and invasive HGSOC. Our findings reveal immune modulating mechanisms within precursor epithelium, characterized by chromosomal instability, persistent IFN signaling, and dysregulated innate and adaptive immunity. FT precursors display elevated expression of MHC class I, including HLA-E, and IFN-stimulated genes, typically linked to later-stage tumorigenesis. These molecular alterations coincide with progressive shifts in the tumor microenvironment, transitioning from immune surveillance in early STICs to immune suppression in advanced STICs and cancer. These insights identify potential biomarkers and therapeutic targets for HGSOC interception and clarify the molecular transitions from precancer to cancer. Significance: This study maps the immune response in FT precursors of HGSOC, highlighting localized IFN signaling, chromosomal instability, and competing immune surveillance and suppression along the progression axis. It provides an explorable public spatial profiling atlas for investigating precancer mechanisms, biomarkers, and early detection and interception strategies. See related commentary by Recouvreux and Orsulic, p. 1093

12 September 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MMMoushami Mallik
Moushami Mallik
MCMarica Catinozzi
Marica Catinozzi
CHClemens B. Hug
Clemens B. Hug
LZLi Zhang
Li Zhang
MWMarina Wagner
Marina Wagner
ESErik Storkebaum
Erik Storkebaum
Cabeza (caz) is the single Drosophila melanogaster orthologue of the human FET proteins FUS, TAF15, and EWSR1, which have been implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. In this study, we identified Xrp1, a nuclear chromatin-binding protein, as a key modifier of caz mutant phenotypes. Xrp1 expression was strongly up-regulated in caz mutants, and Xrp1 heterozygosity rescued their motor defects and life span. Interestingly, selective neuronal Xrp1 knockdown was sufficient to rescue, and neuronal Xrp1 overexpression phenocopied caz mutant phenotypes. The caz/Xrp1 genetic interaction depended on the functionality of the AT-hook DNA-binding domain in Xrp1, and the majority of Xrp1-interacting proteins are involved in gene expression regulation. Consistently, caz mutants displayed gene expression dysregulation, which was mitigated by Xrp1 heterozygosity. Finally, Xrp1 knockdown substantially rescued the motor deficits and life span of flies expressing ALS mutant FUS in motor neurons, implicating gene expression dysregulation in ALS-FUS pathogenesis.